Home/All Molecules/Sevelamer

Sevelamer Range

Comprehensive Sevelamer portfolio for Franchise & Manufacturing.

Category
sevelamer
Total Formulations
2
Available Forms
Tablets

Expand Your Business with Our Multiple Divisions


Browse Sevelamer portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Sevelamer batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Sevelamer PCD Pharma Franchise

Sevelamer PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Sevelamer PCD pharma franchise company offering a portfolio of 2 Sevelamer formulations across tablets. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.

What is Sevelamer?

Sevelamer is a non-absorbed, calcium-free and metal-free phosphate binder. Its polymeric structure binds dietary phosphate in the gastrointestinal tract so it is excreted rather than absorbed, lowering serum phosphate without adding a calcium or aluminium load. The compound record can be reviewed on PubChem.

Therapeutic Applications

Control of hyperphosphataemia in patients with chronic kidney disease, particularly those on dialysis. It is preferred where calcium-based binders risk hypercalcaemia or vascular calcification.

Prescribed by: Nephrologists and dialysis physicians are the near-exclusive prescribers of Sevelamer, with consulting physicians continuing therapy between nephrology reviews.

Why Sevelamer is a High-Potential Molecule for Distributors

Sevelamer is tied to the dialysis population, and dialysis capacity in India has expanded rapidly through both government schemes and private chains. That matters commercially because dialysis patients are on phosphate binders continuously and are treated at identifiable, concentrated sites, so a distributor who establishes supply into nephrology units and dialysis centres captures predictable, institution-linked monthly volume. It is a specialist, low-competition molecule, and the ability to avoid a calcium load is the reason nephrologists keep choosing it over cheaper calcium-based binders.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers its Sevelamer franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Sevelamer business in your region.

References

  1. PubChem – Sevelamer compound record, US National Library of Medicine
  2. PubMed – clinical literature on Sevelamer, NCBI

Aceclofenac in Modern Clinical Practice

Our formulations of Sevelamer find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Sevelamer in PCD Franchise

Start Your Sevelamer Franchise with Cafoli Lifecare

Ready to take monopoly rights for Sevelamer in your district? Talk to our franchise team for net rates, packing details and the current availability list. Call 9518447302 or email info@cafoli.in.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 2 Sevelamer formulations in tablets. The current list with packing and net rates is shared with registered franchise enquiries.

Yes. Monopoly rights for the Sevelamer range are allotted district-wise on a first-come basis and are confirmed in your franchise agreement, so no other Cafoli partner sells the same brands in your territory.

Nephrologists and dialysis physicians are the near-exclusive prescribers of Sevelamer, with consulting physicians continuing therapy between nephrology reviews.

Sevelamer binds dietary phosphate without adding calcium, so it avoids the hypercalcaemia and vascular calcification risk associated with calcium-based binders in long-term dialysis patients. Because dialysis patients take binders continuously, this is a chronic, institution-linked line with steady monthly demand from nephrology and dialysis units.

You need a valid Drug License and a GST registration in your name. Once these are shared along with your territory preference, the Sevelamer franchise agreement and monopoly allotment can be processed.